No information is available on the clinical use of brigatinib during breastfeeding. The manufacturer recommends that breastfeeding be discontinued during brigatinib therapy and for 1 week after the final dose.
关于哺乳期使用布加替尼的临床信息尚无可用资料。制造商建议在布加替尼治疗期间及最后一剂后1周内停止母乳喂养。